ArticleBMC plant biology2026
ZnO and rGO-Based nanoparticles regulate morphophysiological, biochemical, and molecular responses of Phaseolus vulgaris L. under drought and arsenic stress.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Combined arsenic and PEG-induced osmotic stress markedly impaired growth, water status, oxidative balance, and stress-associated metabolism in two Phaseolus vulgaris genotypes (G-53 and G-68). Relative to the non-stressed control, combined stress reduced SPAD values by 6.9% in G-53 and 6.0% in G-68, while increasing cell membrane damage (CMD) by 44.3% and 33.8%, and malondialdehyde (MDA) by 51.0% and 107.1%, respectively. Arsenic accumulated predominantly in roots, whereas nutrient balance and transcriptional responses varied according to genotype and treatment. Plants were pretreated with foliar 0.5% ZnSO4, rGO, ZnO, or rGO-ZnO nanoparticles (NP) and subsequently exposed to single or combined stress conditions. Across the evaluated traits, rGO-ZnO was most frequently associated with attenuation of stress injury. Under combined stress, rGO-ZnO reduced CMD by 19.3% in G-53 and 44.2% in G-68 and reduced MDA by 40.4% and 61.5%, respectively, relative to the corresponding stressed controls. The same treatment increased proline from 1.57 to 2.39 µmol mL− 1 in G-53 and from 0.80 to 3.25 µmol mL− 1 in G-68. RT-qPCR analysis further indicated treatment- and genotype-dependent variation in the relative transcript abundance of genes related to metal transport, signaling, and photosynthetic metabolism. Overall, Zn-based materials, particularly rGO-ZnO NPs, were associated with partial alleviation of combined stress effects; however, treatment-related changes in arsenic partitioning indicate that agronomic relevance should be evaluated alongside food-safety considerations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.